These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34608093)

  • 1. Sebaceous Carcinoma Arising From Heterotopic Salivary Gland Tissue in a Patient With Muir-Torre Syndrome.
    Syder NC; Rabi S; Hu JC
    Dermatol Surg; 2021 Dec; 47(12):1659-1660. PubMed ID: 34608093
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of Muir-Torre Syndrome on Survival in Patients With Sebaceous Carcinoma: A SEER Population-Based Study.
    Tripathi R; Bordeaux JS
    Dermatol Surg; 2019 Jan; 45(1):148-149. PubMed ID: 29578884
    [No Abstract]   [Full Text] [Related]  

  • 3. Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications.
    Shalin SC; Lyle S; Calonje E; Lazar AJ
    Histopathology; 2010 Jan; 56(1):133-47. PubMed ID: 20055911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extraocular sebaceous carcinoma: a report of 2 cases.
    Cieza-Díaz DE; Cano-Martínez N; Barchino-Ortiz L; Longo-Imedio I
    Actas Dermosifiliogr; 2012 Dec; 103(10):919-22. PubMed ID: 23149052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deceptively Innocent Façade of Sebaceous Carcinoma in Muir-Torre Syndrome.
    Cox SV; Smith J
    Dermatol Surg; 2021 Jun; 47(6):828-829. PubMed ID: 33038102
    [No Abstract]   [Full Text] [Related]  

  • 6. Cystic sebaceous tumour with no evidence of Muir-Torre syndrome.
    Woo JY; Suhng EA; Choi YW; Choi HY; Byun JY
    J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):1038-9. PubMed ID: 25753622
    [No Abstract]   [Full Text] [Related]  

  • 7. Sebaceous adenoma arising within an ovarian mature cystic teratoma in Muir-Torre syndrome.
    Smith J; Crowe K; McGaughran J; Robertson T
    Ann Diagn Pathol; 2012 Dec; 16(6):485-8. PubMed ID: 21684182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is a cystic sebaceous neoplasm always marker for Muir-Torre syndrome?
    Arsenovic N; Ramaiya A
    Dermatol Online J; 2009 Nov; 15(11):11. PubMed ID: 19951647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch syndrome.
    Roberts ME; Riegert-Johnson DL; Thomas BC; Rumilla KM; Thomas CS; Heckman MG; Purcell JU; Hanson NB; Leppig KA; Lim J; Cappel MA
    Genet Med; 2014 Sep; 16(9):711-6. PubMed ID: 24603434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor (EGFR) expression in periocular and extraocular sebaceous carcinoma.
    Ivan D; Prieto VG; Esmaeli B; Wistuba II; Tang X; Lazar AJ
    J Cutan Pathol; 2010 Feb; 37(2):231-6. PubMed ID: 19614729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sebaceous neoplasms and the Muir-Torre syndrome.
    Elston DM
    J Am Acad Dermatol; 2023 Dec; 89(6):1123. PubMed ID: 37172735
    [No Abstract]   [Full Text] [Related]  

  • 12. Muir-Torre Syndrome in a Middle-Aged Chinese Patient with Sebaceous Carcinoma of the Eyelid.
    Wong CY; Tang RK; Lam RF; Io IY; Yuen CY; Ho JW; Tse RK
    Semin Ophthalmol; 2015; 30(5-6):420-2. PubMed ID: 24117411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Isolated conjunctival sebaceous adenoma associated with acute endophtalmitis].
    Tresserra F; Elizalde J; Ferre B; Gómez-Benlloch A; Martínez-Lanao MÁ; López R
    Rev Esp Patol; 2022; 55(1):68-72. PubMed ID: 34980445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemistry screening of sebaceous lesions for Muir-Torre syndrome in a 26-year period in a Mexican population.
    Archer-Dubon C; Alvarez-Zavala B; Reyes E; Orozco-Topete R
    Dermatol Online J; 2008 Dec; 14(12):1. PubMed ID: 19265614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, dermoscopic and reflectance confocal microscopy features of sebaceous neoplasms in Muir-Torre syndrome.
    Moscarella E; Argenziano G; Longo C; Cota C; Ardigò M; Stigliano V; Mete LS; Donati P; Piana S; Silipo V; Catricalà C; Albertini G; Zalaudek I
    J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):699-705. PubMed ID: 22471909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraocular sebaceous carcinoma in a patient with Muir-Torre syndrome.
    Harrington CR; Egbert BM; Swetter SM
    Dermatol Surg; 2004 May; 30(5):817-9. PubMed ID: 15099333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sebaceous Carcinoma in Situ Masquerading Clinically and Histologically as Paget Disease of the Breast.
    Tjarks BJ; Kerkvliet AM; Jassim AD
    S D Med; 2018 Aug; 71(8):350-353. PubMed ID: 30110525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of the current medical literature and assessment of current utilization patterns regarding mismatch repair protein immunohistochemistry in cutaneous Muir-Torre syndrome-associated neoplasms.
    Lee JB; Litzner BR; Vidal CI
    J Cutan Pathol; 2017 Nov; 44(11):931-937. PubMed ID: 28749576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sebaceous lesions of the skin.
    Iacobelli J; Harvey NT; Wood BA
    Pathology; 2017 Dec; 49(7):688-697. PubMed ID: 29078997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Muir-Torre syndrome associated with Waldenstrom's macroglobulinemia].
    Velter C; Bourlond F; Wettle C; Lioure B; Lipsker D; Maugard C; Cribier B
    Ann Dermatol Venereol; 2016 Dec; 143(12):825-830. PubMed ID: 27771121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.